Le Lézard
Classified in: Health, Science and technology
Subjects: LAW, PLW

Nox Medical Achieves Success in Patent Infringement Lawsuit


REYKJAVIK, Iceland, May 21, 2018 /PRNewswire/ --

Nox Medical, a leading sleep diagnostic medical device company and innovator has achieved a major success in its case in the U.S. District Court for the District of Delaware alleging that Natus Neurology willfully infringed Nox Medical's U.S. Patent No. 9,059,532 covering the biometric connector on its disposable RIP belts.

     (Logo: https://mma.prnewswire.com/media/693700/Nox_Medical_Logo.jpg )

Nox Medical's claims for willful infringement by Natus, and Natus' defense of patent invalidity were tried to a jury over three days.  The jury returned a verdict upholding the validity of all asserted claims of the '532 patent, awarding Nox Medical damages for Natus' infringement, and finding that Natus' infringement of the '532 patent was willful.  This victory is now the third in a string of victories against Natus regarding Nox Medical's biometric connector on its disposable RIP belts, Nox Medical having previously prevailed in an opposition proceeding for the European counterpart to the '532 patent, and a victory over Natus' challenge to the '532 patent in an IPR proceeding before the U.S. Patent and Trademark Office.  Nox Medical will continue its pursuit of justice by requesting the court to enhance the damages awarded by the jury due to Natus' willful infringement, and to award Nox Medical its attorneys' fees.      

"This was an important and long-awaited victory for Nox Medical," said Petur Mar Halldorsson, CEO of Nox Medical. "We have been forced to battle this litigation for over two years because Nox Medical believes in its technology and in its intellectual property.  Nox Medical was founded on innovation, and innovation continues to be Nox Medical's distinguishing characteristic.  Consequently, when Natus copied our invention Nox Medical was compelled to protect its intellectual property despite going against a much larger competitor with far more resources to dedicate to the litigation.  Nonetheless, we had confidence that our patent would survive all Natus' attacks, and that the jury would hold Natus accountable for willfully infringing the '532 patent.  This victory is not only important for Nox Medical, but the entire industry as it fosters continued innovation in the whole field of sleep diagnostics," continued Petur. "Respect for innovation and intellectual property is particularly important in the field of medical devices. As soon as one large company starts to infringe on the innovation of others in the field it will cause stagnation and will be detrimental to everyone in the field," said Petur. "We will continue to protect our intellectual property, not only with our own best interest at heart, but also to encourage others in the field to innovate and push boundaries," concluded Petur.

About Nox Medical 

Nox Medical is an award-winning company in the field of sleep diagnostic medical devices. Its solutions help medical professionals diagnose and treat people with sleep disorders. Nox Medical is a global leader with more than 30 distributors all over the world. The Nox Medical team is committed to advancing sleep diagnostics through continued investment in research and development.

For more information please contact Petur Mar Halldorsson, CEO at +354-692-2242.

http://www.noxmedical.com


These press releases may also interest you

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...

at 06:00
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to ?275 Million, Consisting of ?190 Million in Cash Upfront and up to ?85 Million in...

at 06:00
Dr. Luz Hernandez, a leading dentist in Tampa, Florida has redefined her practice to focus on facial aesthetics. Facial Aesthetics by Dr. Luz, https://www.drluzh.com/, provides a wide...

at 06:00
West Pharmaceutical Services, Inc. today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance....

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...



News published on and distributed by: